Gilenya LawsuitGilenya, a multiple sclerosis drug, has recently been linked to 11 deaths, prompting the FDA to launch a new safety review. Some Gilenya patients died from heart problems shortly following their first dose of the medication, raising concerns that the drug may cause cardiovascular problems. The drug’s safety label already recommends that people be monitored… Read More









